| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
AFFIRM and RACE Trials Implications for the Management of Atrial Fibrillation
|
Joseph L. Blackshear
|
|
2003
|
7 |
4 |
p. 366-369
4 p.
|
artikel
|
| 2 |
AFFIRM and RACE Trials: Implications for the Management of Atrial Fibrillation
|
Blackshear, Joseph L.
|
|
2003
|
7 |
4 |
p. 366-369
|
artikel
|
| 3 |
Amiodarone versus Implantable Defibrillator (AMIOVIRT) Background, Rationale, Design, Methods, Results and Implications
|
Mevan Wijetunga
|
|
2003
|
7 |
4 |
p. 452-456
5 p.
|
artikel
|
| 4 |
Amiodarone versus Implantable Defibrillator (AMIOVIRT): Background, Rationale, Design, Methods, Results and Implications
|
Wijetunga, Mevan
|
|
2003
|
7 |
4 |
p. 452-456
|
artikel
|
| 5 |
AspirinAnticoagulant Combination in Patients with Non Valvular Atrial Fibrillation Commentary on the FFAACS Study Results
|
Philippe P. Lechat
|
|
2003
|
7 |
4 |
p. 372-373
2 p.
|
artikel
|
| 6 |
Aspirin—Anticoagulant Combination in Patients with Non Valvular Atrial Fibrillation Commentary on the FFAACS Study Results
|
Lechat, Philippe P.
|
|
2003
|
7 |
4 |
p. 372-373
|
artikel
|
| 7 |
Atrial Arrhythmia Burden as an Endpoint in Clinical Trials Is it the Best Surrogate Lessons from a Multicenter Defibrillator Trial
|
David E. Euler
|
|
2003
|
7 |
4 |
p. 355-358
4 p.
|
artikel
|
| 8 |
Atrial Arrhythmia Burden as an Endpoint in Clinical Trials: Is it the Best Surrogate? Lessons from a Multicenter Defibrillator Trial
|
Euler, David E.
|
|
2003
|
7 |
4 |
p. 355-358
|
artikel
|
| 9 |
Atrial Fibrillation Should we Target Platelets or the Coagulation Pathway
|
Kiat T. Tan
|
|
2003
|
7 |
4 |
p. 370-371
2 p.
|
artikel
|
| 10 |
Atrial Fibrillation: Should we Target Platelets or the Coagulation Pathway?
|
Tan, Kiat T.
|
|
2003
|
7 |
4 |
p. 370-371
|
artikel
|
| 11 |
Atrial Pacing Therapies for Prevention of Atrial Fibrillation in Patients with Implantable Defibrillators
|
Anne M. Gillis
|
|
2003
|
7 |
4 |
p. 345-347
3 p.
|
artikel
|
| 12 |
Atrial Pacing Therapies for Prevention of Atrial Fibrillation in Patients with Implantable Defibrillators
|
Gillis, Anne M.
|
|
2003
|
7 |
4 |
p. 345-347
|
artikel
|
| 13 |
Cardiac Resynchronization Therapy with or without an Implantable Defibrillator Only Indicated When Everything Else has Failed
|
J. Ghosh
|
|
2003
|
7 |
4 |
p. 421-429
9 p.
|
artikel
|
| 14 |
Cardiac Resynchronization Therapy with or without an Implantable Defibrillator: Only Indicated When Everything Else has Failed?
|
Ghosh, J.
|
|
2003
|
7 |
4 |
p. 421-429
|
artikel
|
| 15 |
Cardioversion Related Thromboembolism Value of Transesophageal Echocardiography to Guide Cardioversion in Patients with Atrial Fibrillation
|
Karlheinz Seidl
|
|
2003
|
7 |
4 |
p. 392-396
5 p.
|
artikel
|
| 16 |
Cardioversion Related Thromboembolism: Value of Transesophageal Echocardiography to Guide Cardioversion in Patients with Atrial Fibrillation
|
Seidl, Karlheinz
|
|
2003
|
7 |
4 |
p. 392-396
|
artikel
|
| 17 |
Clinical Significance of Device-Related Complications in Clinical Trials and Implications for Future Trials Insights from the Antiarrhytmics versus Implantable Defibrillators (AVID) Trial
|
Jack Kron
|
|
2003
|
7 |
4 |
p. 473-478
6 p.
|
artikel
|
| 18 |
Clinical Significance of Device-Related Complications in Clinical Trials and Implications for Future Trials: Insights from the Antiarrhytmics versus Implantable Defibrillators (AVID) Trial
|
Kron, Jack
|
|
2003
|
7 |
4 |
p. 473-478
|
artikel
|
| 19 |
Clinical Trials of Prophylactic Implantable Defibrillator Therapy in Patients with Nonischemic Cardiomyopathy What have We Learned and What can We Expect from Future Trials
|
Wolfram Grimm
|
|
2003
|
7 |
4 |
p. 463-467
5 p.
|
artikel
|
| 20 |
Clinical Trials of Prophylactic Implantable Defibrillator Therapy in Patients with Nonischemic Cardiomyopathy: What have We Learned and What can We Expect from Future Trials?
|
Grimm, Wolfram
|
|
2003
|
7 |
4 |
p. 463-467
|
artikel
|
| 21 |
Comparison of Permanent Left Ventricular and Biventricular Pacing in Patients with Heart Failure and Chronic Atrial Fibrillation A Prospective Hemodynamic Study
|
Stephane Garrigue
|
|
2003
|
7 |
4 |
p. 315-324
10 p.
|
artikel
|
| 22 |
Comparison of Permanent Left Ventricular and Biventricular Pacing in Patients with Heart Failure and Chronic Atrial Fibrillation: A Prospective Hemodynamic Study
|
Garrigue, Stephane
|
|
2003
|
7 |
4 |
p. 315-324
|
artikel
|
| 23 |
Cost-Effectiveness of the Implantable Cardioverter Defibrillator
|
Mark A. Hlatky
|
|
2003
|
7 |
4 |
p. 479-482
4 p.
|
artikel
|
| 24 |
Cost-Effectiveness of the Implantable Cardioverter Defibrillator
|
Hlatky, Mark A.
|
|
2003
|
7 |
4 |
p. 479-482
|
artikel
|
| 25 |
DEFibrillators In Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE)
|
Andi Schaechter
|
|
2003
|
7 |
4 |
p. 457-462
6 p.
|
artikel
|
| 26 |
DEFibrillators In Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE)
|
Schaechter, Andi
|
|
2003
|
7 |
4 |
p. 457-462
|
artikel
|
| 27 |
Detection of Atrial Fibrillation by Permanent Pacemakers Observations from the STOP AF Trial
|
C.J. Plummer
|
|
2003
|
7 |
4 |
p. 333-340
8 p.
|
artikel
|
| 28 |
Detection of Atrial Fibrillation by Permanent Pacemakers: Observations from the STOP AF Trial
|
Plummer, C.J.
|
|
2003
|
7 |
4 |
p. 333-340
|
artikel
|
| 29 |
Do Anticoagulation Management Services Improve Care Implications of the Managing Anticoagulation Services Trial
|
David B. Matchar
|
|
2003
|
7 |
4 |
p. 379-381
3 p.
|
artikel
|
| 30 |
Do Anticoagulation Management Services Improve Care? Implications of the Managing Anticoagulation Services Trial
|
Matchar, David B.
|
|
2003
|
7 |
4 |
p. 379-381
|
artikel
|
| 31 |
Does Rapid Atrial Pacing Terminate Atrial Fibrillation A Comparison of Laboratory and Device Termination Studies
|
Andrew R.J. Mitchell
|
|
2003
|
7 |
4 |
p. 352-354
3 p.
|
artikel
|
| 32 |
Does Rapid Atrial Pacing Terminate Atrial Fibrillation? A Comparison of Laboratory and Device Termination Studies
|
Mitchell, Andrew R.J.
|
|
2003
|
7 |
4 |
p. 352-354
|
artikel
|
| 33 |
Does Sinus Rhythm Beget Sinus Rhythm Effects of Prompt Cardioversion on the Frequency and Persistence of Recurrent Atrial Fibrillation
|
Hung-Fat Tse
|
|
2003
|
7 |
4 |
p. 359-365
7 p.
|
artikel
|
| 34 |
Does Sinus Rhythm Beget Sinus Rhythm? Effects of Prompt Cardioversion on the Frequency and Persistence of Recurrent Atrial Fibrillation
|
Tse, Hung-Fat
|
|
2003
|
7 |
4 |
p. 359-365
|
artikel
|
| 35 |
Editorial The Future of Cardiac Electrophysiology Review
|
Kelley P. Anderson
|
|
2003
|
7 |
4 |
p. 311-311
1 p.
|
artikel
|
| 36 |
Editorial: The Future of Cardiac Electrophysiology Review
|
Anderson, Kelley P.
|
|
2003
|
7 |
4 |
p. 311
|
artikel
|
| 37 |
Effectiveness of Rapid Atrial Pacing for Termination of Drug Refractory Atrial Fibrillation Results of a Dual Chamber Implantable Cardioverter Defibrillator Trial
|
Michael R. Gold
|
|
2003
|
7 |
4 |
p. 341-344
4 p.
|
artikel
|
| 38 |
Effectiveness of Rapid Atrial Pacing for Termination of Drug Refractory Atrial Fibrillation: Results of a Dual Chamber Implantable Cardioverter Defibrillator Trial
|
Gold, Michael R.
|
|
2003
|
7 |
4 |
p. 341-344
|
artikel
|
| 39 |
Efficacy of Atrial Antitachycardia Functions for Treating Atrial Fibrillation Observations in Patients with a Dual-Chamber Defibrillator
|
Renato Ricci
|
|
2003
|
7 |
4 |
p. 348-351
4 p.
|
artikel
|
| 40 |
Efficacy of Atrial Antitachycardia Functions for Treating Atrial Fibrillation: Observations in Patients with a Dual-Chamber Defibrillator
|
Ricci, Renato
|
|
2003
|
7 |
4 |
p. 348-351
|
artikel
|
| 41 |
Enhancing Specificity Without Sacrificing Sensitivity Potential Benefits of Using Microvolt T-Wave Alternans Testing to Risk Stratify the MADIT-II Population
|
Richard J. Cohen
|
|
2003
|
7 |
4 |
p. 438-442
5 p.
|
artikel
|
| 42 |
Enhancing Specificity Without Sacrificing Sensitivity: Potential Benefits of Using Microvolt T-Wave Alternans Testing to Risk Stratify the MADIT-II Population
|
Cohen, Richard J.
|
|
2003
|
7 |
4 |
p. 438-442
|
artikel
|
| 43 |
Is Bachmann's Bundle the Only Right Site for Single-Site Pacing to Prevent Atrial Fibrillation Results of a Multicenter Randomized Trial
|
Steven J. Bailin
|
|
2003
|
7 |
4 |
p. 325-328
4 p.
|
artikel
|
| 44 |
Is Bachmann's Bundle the Only Right Site for Single-Site Pacing to Prevent Atrial Fibrillation? Results of a Multicenter Randomized Trial
|
Bailin, Steven J.
|
|
2003
|
7 |
4 |
p. 325-328
|
artikel
|
| 45 |
Low Molecular Weight Heparin in Atrial Fibrillation Management Facts, Fiction, Future
|
Michael H. Kim
|
|
2003
|
7 |
4 |
p. 397-400
4 p.
|
artikel
|
| 46 |
Low Molecular Weight Heparin in Atrial Fibrillation Management: Facts, Fiction, Future
|
Kim, Michael H.
|
|
2003
|
7 |
4 |
p. 397-400
|
artikel
|
| 47 |
MADIT-II Substudies and Their Implications
|
Arthur J. Moss
|
|
2003
|
7 |
4 |
p. 430-433
4 p.
|
artikel
|
| 48 |
MADIT-II: Substudies and Their Implications
|
Moss, Arthur J.
|
|
2003
|
7 |
4 |
p. 430-433
|
artikel
|
| 49 |
Multisite Atrial Pacing for Atrial Fibrillation Prevention Where to Go from Here
|
Anand Ramdat Misier
|
|
2003
|
7 |
4 |
p. 329-332
4 p.
|
artikel
|
| 50 |
Multisite Atrial Pacing for Atrial Fibrillation Prevention: Where to Go from Here?
|
Misier, Anand Ramdat
|
|
2003
|
7 |
4 |
p. 329-332
|
artikel
|
| 51 |
Oral Anticoagulants vs. Aspirin for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation The Verdict is in
|
Carl van Walraven
|
|
2003
|
7 |
4 |
p. 374-378
5 p.
|
artikel
|
| 52 |
Oral Anticoagulants vs. Aspirin for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation: The Verdict is in
|
van Walraven, Carl
|
|
2003
|
7 |
4 |
p. 374-378
|
artikel
|
| 53 |
Pacing for Vasovagal Syncope After the Second Vasovagal Pacemaker Study (VPS II) A Matter of Judgement
|
Geoffrey M. Trim
|
|
2003
|
7 |
4 |
p. 416-420
5 p.
|
artikel
|
| 54 |
Pacing for Vasovagal Syncope After the Second Vasovagal Pacemaker Study (VPS II): A Matter of Judgement
|
Trim, Geoffrey M.
|
|
2003
|
7 |
4 |
p. 416-420
|
artikel
|
| 55 |
Relationships between Pacing Mode and Quality of Life Evidence from Randomized Clinical Trials
|
David Newman
|
|
2003
|
7 |
4 |
p. 401-405
5 p.
|
artikel
|
| 56 |
Relationships between Pacing Mode and Quality of Life: Evidence from Randomized Clinical Trials
|
Newman, David
|
|
2003
|
7 |
4 |
p. 401-405
|
artikel
|
| 57 |
Risk Stratification for Sudden Death Do We Need Anything More Than Ejection Fraction
|
Alfred E. Buxton
|
|
2003
|
7 |
4 |
p. 434-437
4 p.
|
artikel
|
| 58 |
Risk Stratification for Sudden Death: Do We Need Anything More Than Ejection Fraction?
|
Buxton, Alfred E.
|
|
2003
|
7 |
4 |
p. 434-437
|
artikel
|
| 59 |
Second Vasovagal Pacemaker Study (VPS II) Rationale, Design, Results, and Implications for Practice and Future Clinical Trials
|
Robert Sheldon
|
|
2003
|
7 |
4 |
p. 411-415
5 p.
|
artikel
|
| 60 |
Second Vasovagal Pacemaker Study (VPS II): Rationale, Design, Results, and Implications for Practice and Future Clinical Trials
|
Sheldon, Robert
|
|
2003
|
7 |
4 |
p. 411-415
|
artikel
|
| 61 |
Selecting the Appropriate Pacing Mode for Patients with Sick Sinus Syndrome Evidence from Randomized Clinical Trials
|
A.E. Albertsen
|
|
2003
|
7 |
4 |
p. 406-410
5 p.
|
artikel
|
| 62 |
Selecting the Appropriate Pacing Mode for Patients with Sick Sinus Syndrome: Evidence from Randomized Clinical Trials
|
Albertsen, A.E.
|
|
2003
|
7 |
4 |
p. 406-410
|
artikel
|
| 63 |
Selection of Pacing Mode after Interruption of Atrioventricular Conduction for Atrial Fibrillation Observations from the PA3 Clinical Trial
|
Anne M. Gillis
|
|
2003
|
7 |
4 |
p. 312-314
3 p.
|
artikel
|
| 64 |
Selection of Pacing Mode after Interruption of Atrioventricular Conduction for Atrial Fibrillation: Observations from the PA3 Clinical Trial
|
Gillis, Anne M.
|
|
2003
|
7 |
4 |
p. 312-314
|
artikel
|
| 65 |
The Defibrillator in Acute Myocardial Infarction Trial (DINAMIT) Rationale, Design and Specific Aims
|
Gerian Grönefeld
|
|
2003
|
7 |
4 |
p. 447-451
5 p.
|
artikel
|
| 66 |
The Defibrillator in Acute Myocardial Infarction Trial (DINAMIT): Rationale, Design and Specific Aims
|
Grönefeld, Gerian
|
|
2003
|
7 |
4 |
p. 447-451
|
artikel
|
| 67 |
The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial Rationale, Design, Results, Clinical Implications and Lessons for Future Trials
|
Bruce L. Wilkoff
|
|
2003
|
7 |
4 |
p. 468-472
5 p.
|
artikel
|
| 68 |
The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: Rationale, Design, Results, Clinical Implications and Lessons for Future Trials
|
Wilkoff, Bruce L.
|
|
2003
|
7 |
4 |
p. 468-472
|
artikel
|
| 69 |
Transesophageal Echocardiography to Guide Cardioversion in Patients with Atrial Fibrillation ACUTE Trial Update
|
Craig R. Asher
|
|
2003
|
7 |
4 |
p. 387-391
5 p.
|
artikel
|
| 70 |
Transesophageal Echocardiography to Guide Cardioversion in Patients with Atrial Fibrillation: ACUTE Trial Update
|
Asher, Craig R.
|
|
2003
|
7 |
4 |
p. 387-391
|
artikel
|
| 71 |
Use of Subcutaneous Enoxaparin Compared to Intravenous Heparin and Oral Phenprocoumon in the Setting of CardioversionThe ACE Study (Anticoagulation in Cardioversion Using Enoxaparin)
|
Christoph Stellbrink
|
|
2003
|
7 |
4 |
p. 382-386
5 p.
|
artikel
|
| 72 |
Use of Subcutaneous Enoxaparin Compared to Intravenous Heparin and Oral Phenprocoumon in the Setting of Cardioversion—The ACE Study (Anticoagulation in Cardioversion Using Enoxaparin)
|
Stellbrink, Christoph
|
|
2003
|
7 |
4 |
p. 382-386
|
artikel
|
| 73 |
Using the MADIT II Criteria for Implantable Cardioverter DefibrillatorsWhat is the Role of the Food and Drug Administration Approval
|
Helen S. Barold
|
|
2003
|
7 |
4 |
p. 443-446
4 p.
|
artikel
|
| 74 |
Using the MADIT II Criteria for Implantable Cardioverter Defibrillators—What is the Role of the Food and Drug Administration Approval?
|
Barold, Helen S.
|
|
2003
|
7 |
4 |
p. 443-446
|
artikel
|
Tijdschrift beschrijving